Abstract
Parylene is a biologically inert material capable of being deposited in conformal nanoscale layers on virtually any surface, making it a viable structural material for the fabrication of drug delivery devices, as well as implant coatings, sensors, and other biomedical technologies. Here we explore its novel drug delivery applications by using parylene to package the polymethyloxazoline-polydimethylsiloxane-polymethyloxazoline (PMOXA-PDMS-PMOXA) block copolymer membrane of a nanoscale thickness (~4 nm/layer) mixed with a therapeutic element, creating an active parylene-encapsulated copolymeric (APC) membrane for slow release drug delivery of dexamethasone (Dex), a potent anti-inflammatory and immunosuppressant synthetic glucocorticoid. Given current needs for localized therapeutic release for conditions such as cancer, post-surgical inflammation, wound healing, regenerative medicine, to name a few, this stand-alone and minimally invasive implantable technology may impact a broad range of medical scenarios. To evaluate the applicability of the APC membrane as a biocompatible drug delivery system, real-time polymerase chain reaction (RT-PCR) was performed to investigate the expression of cytokines that regulate cellular stress and inflammation as a result of in vitro RAW264.7 macrophage cell growth on the APC membrane. Significant decreases in relative mRNA levels of IL-6, TNF-α, and iNOS were observed. Dex functionalized APC membranes were further found to effectively slow-elute the drug via confocal microscopy, with a confirmed extended elution capability over a period of several days, undergoing phosphate buffered saline washes between time points. In addition, we examined the membrane surface through atomic force microscopy (AFM) to examine Dex/copolymer deposition, and to characterize the surface of the APC membrane. Furthermore, we evaluated the effects of incubation with the APC membrane in solution on macrophage growth behavior and cellular adhesion, including the physical properties of parylene and the copolymer to elucidate the anti-adhesive responses we observed. The results of this study will provide insight into ultra-thin and flexible devices of parylene-encapsulated copolymer membranes as platform drug delivery technologies capable of localized and precision therapeutic drug elution.
Similar content being viewed by others
References
55. Akakura, K., H. Suzuki. T. Ueda, A. Komiya, T. Ichikawa, T. Igarashi, H. Ito. 2003. Possible mechanism of dexamethasone therapy for prostate cancer: suppression of circulating level of interleukin-6. The Prostate. 56: 106-109. doi:10.1002/pros.10231
25. Boduroglu, S., M. Cetinkaya, W.J. Dressick, A. Singh, and M.C. Demirel. 2007. Controlling the wettability and adhesion of nanostructured poly-(p-xylylene) films. Langmuir. 23: 11391-11395. doi:10.1021/la7025413
48. Brodbeck, W.G., J. Patel, G. Voskerician, E. Christenson, M.S. Shive, Y. Nakayama, T. Matsuda, N.P. Ziats, J.M. Anderson. 2002. Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo. Proc. Nat. Acad. Sci-USA. 99: 10287-10292. doi:10.1073/pnas.162124199
3. Burt, H.M., W.L. Hunter. 2006. Drug-eluting stents: A multidisciplinary success story. Adv. Drug Del. Rev. 58: 350-357. doi:10.1016/j.addr.2006.01.014
4. Burt, H.M., and W.L. Hunter. 2006. Drug-eluting stents: an innovative multidisciplinary delivery platform. Adv. Drug Del. Rev. 58: 345-346. doi:10.1016/j.addr.2006.02.001
45. Buzin, A.I., D.S. Bartolome, K.A. Mailyan, A.V. Pebalk, S.N. Chvalun. 2006. Surface morphology of poly(cyano-p-xylylene) thin films. Polym. Sci. Ser. A. 48: 961-966. doi:10.1134/S0965545X06090112
35. Chen, P., D.C. Rodger, E.M. Meng, M.S. Humayun, Y.-C. Tai. 2007. Surface-micromachined parylene dual valves for on-chip unpowered microflow regulation. J. Microelectromech. Sys. 16: 223-231. doi:10.1109/JMEMS.2006.889534
1. Cheng, J., B.A. Teply, S.Y. Jeong, C.H. Yim, D. Ho, I. Sherifi, S. Jon, O.C. Farokhzad, A. Khademhosseini, R.S. Langer. 2006. Magnetically responsive polymeric microparticles for oral delivery of protein drugs. Pharmaceutical Res. 23: 557-564. doi:10.1007/s11095-005-9444-5
22. Chow, E., E. Pierstorff, G. Cheng, D. Ho. 2008. Nanofilm copolymer platform for controlled drug delivery. ACS Nano. 2: 33-40. doi:10.1021/nn7000917
43. Chow, E.K., E. Pierstorff, G. Cheng, Y.-C. Tai, D. Ho. 2007. Attenuation of Cellular Inflammation Using Glucocorticoid-Functionalized Copolymers. IEEE Proc. NEMS. 2:1039-1043.
9. Chung, H.J., T.G. Park. 2007. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv. Drug Del. Rev. 59: 249-262. doi:10.1016/j.addr.2007.03.015
53. Cohen J.J., R.P. Schlerimer, H.N. Claman, A.L. Oronsky. 1989. Anti-Inflammatory Steroid Action, Basic and Clinical Aspects. San Diego: Academic Press. pp. 111-131.
46. Collier, T.O., J.M. Anderson, W.G. Brodbeck, T. Barber, K.E. Healy. 2004. Inhibition of macrophage development and foreign body giant cell formation by hydrophilic interpenetrating polymer network. J. Biomed. Mater. Res. Part A. 69A: 644-650. doi:10.1002/jbm.a.30030
52. D’Acquisto, F., L. Cicatiello, T. Iuvone, A. Ialenti, A. Ianaro, H. Esumi, A. Weisz, R. Carnuccio. 1997. Inhibition of inducible nitric oxide synthase gene expression by glucocorticoid-induced protein(s) in lipopolysaccharide-stimulated J774 cells. Euro. J. Pharmacol. 339: 87-95. doi:10.1016/S0014-2999(97)01361-7
59. De Vera, M.E., B.S. Taylor, Q. Wang, R.A. Shapiro, T.R. Billiar, D.A. Geller. 1997. Dexamethasone suppresses iNOS gene expression by upregulating I-κBα and inhibiting NF-κB. Am. J. Physiol. Gastrointest. Liver Physiol. 273: 1290-1296.
29. Fan, Z., J.M. Engel, J. Chen, C. Liu. 2004. Parylene surface-micromachined membranes for sensor applications. J. Microelectromechanical Sys. 13: 484-490. doi:10.1109/JMEMS.2004.825295
33. Fontaine, A.B., K. Koelling, S.D. Passos, J. Cearlock, R. Hoffman, D.G. Spigos. 1996. Polymeric surface modifications of tantalum stents. J. Endovasc. Surg. 3: 276-283. doi:10.1583/1074-6218(1996)003<0276:PSMOTS>2.0.CO;2
63. Gasion, J.P.B., J.F.J. Cruz. 2006. Improving efficacy of intravesical chemotherapy. Euro. Urol. 50: 225-234. doi:10.1016/j.eururo.2006.05.035
21. Gifford, R., M.M. Batchelor, Y. Lee, G. Gokulrangan, M.E. Meyerhoff, G.S. Wilson. 2005. Mediation ofin vivo glucose sensor inflammatory response via nitric oxide release. J. Biomed. Mater. Res. A.75: 755-766. doi:10.1002/jbm.a.30359
47. Goschel, U., H. Walter. 2000. Surface film formation by chemical vapor deposition of di-p-xylylene: ellipsometrical, atomic force microscopy, and x-ray studies. Langmuir. 16: 2887-2892. doi:10.1021/la9908743
38. Grattan, D.W., M. Bilz. 1991. The Thermal Aging of Parylene and the Effect of Antioxidant. Studies in Conservation. 36: 44-52. doi:10.2307/1506451
39. Greiner, A. 1996. Poly(p-xylylene)s (structure, properties, and applications). The Polymeric Materials Encyclopedia. 9: 7171-7180.
10. Grube, E., L. Buellesfeld, F.J. Neumann, S. Verheye, A. Abizaid, D. McClean, R. Mueller, A. Lansky, R. Mehran, R. Costa, U. Gerckens, B. Trauthen, P.J. Fitzgerald. 2007. Six-month clinical and angiographic results of a dedicated drug-eluting stent for the treatment of coronary bifurcation narrowings. Am. J. Cardiol. 99: 1691-1697. doi:10.1016/j.amjcard.2007.01.043
31. He, Q., E. Meng, Y.-C. Tai, C.M. Rutherglen, J. Erickson, J. Pine. 2003. Parylene neuro-cages for live neural networks study. Proc. Transducers. 12: 995-998.
51. Hoffmann, A., D. Baltimore. 2006. Circuitry of nuclear factor κB signaling. Immunol. Rev. 210: 171-186. doi:10.1111/j.0105-2896.2006.00375.x
20. Konttinen, Y.T., D. Zhao, A. Beklen, G. Ma, M. Takagi, M. Kivela-Rajamaki, N. Ashammakhi, S. Santavirta. 2005. The microenvironment around total hip replacement prostheses. Clin. Orthop. Relat. Res. 430: 28-38. doi:10.1097/01.blo.0000150451.50452.da
58. Korhonen, R., A. Lahti, M. Hamalainen, H. Kankaanranta, E. Moilanen. 2002. Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages. Mol. Pharmacol. 62: 698-704. doi:10.1124/mol.62.3.698
5. Krucoff, M.W., A. Boam, D.G. Schultz. 2007. Drug-eluting stents “deliver heartburn”: How do we spell relief going forward? Circulation. 115: 2990-2994. doi:10.1161/CIRCULATIONAHA.107.707778
26. Krupin, T., A.I. Mandell, S.M. Podos, B. Becker. 1976. Topical corticosteroid therapy and pituitary-adrenal function. Arch. Ophthalmol. 94: 919-920.
28. Lam, R., M. Chen, E. Pierstorff, H. Huang, E. Osawa, D. Ho. 2008. Nanodiamond-Embedded Microfilm Devices for Localized Chemotherapeutic Elution. ACS Nano. 2: 2095-2102. doi:10.1021/nn800465x
49. Leporatti, S., A. Gerth, G. Kohler, B. Kohlstrunk, S. Hauschildt, E. Donath. 2006. Elasticity and adhesion of resting and lipopolysaccharide-stimulated macrophages. FEBS Lett. 580: 450-454. doi:10.1016/j.febslet.2005.12.037
56. Maeda, K., K. Yoshida, I. Ichimiya, M. Suzuki. 2005. Dexamethasone inhibits tumor necrosis factor-α-induced cytokine secretion from spiral ligament fibrocytes. Hearing Res. 202: 154-160. doi:10.1016/j.heares.2004.08.022
6. Malafaya, P.B., G.A. Silva, E.T. Baran, R.L. Reis. 2002. Drug delivery therapies I General trends and its importance on bone tissue engineering applications. Curr. Opin. Sol. State and Mat. Sci. 6:283-295. doi:10.1016/S1359-0286(02)00075-X
50. Nakashima, Y., D.-H. Sun, M.C.D. Trindade, W.J. Maloney, S.B. Goodman, D.J. Schurman, R.L. Smith. 1999. Signaling pathways for tumor necrosis factor-α and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro J. Bone Joint Surg. Am. 81: 603-615. doi:10.1302/0301-620X.81B1.8884
42. Nardin, C., M. Winterhalter, W. Meier. 2000. Giant free-standing ABA triblock copolymer membranes. Langmuir. 16: 7708-7712. doi:10.1021/la000204t
37. Neeves, K.B., C.T. Lo, C.P. Foley, W.M. Saltzman, W.L. Olbricht. 2006. Fabrication and characterization of microfluidic probes for convection enhanced drug delivery. J. Control. Rel. 111: 252-262. doi:10.1016/j.jconrel.2005.11.018
60. Pascual, G., C.K. Glass. 2006. Nuclear receptors versus inflammation: mechanisms of transrepression. Trends Endocrinol. Metab. 17: 321-327. doi:10.1016/j.tem.2006.08.005
12. Pfisterer, M., H.P. Brunner-La Rocca, P.T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser. 2006. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. An observational study of drug-eluting versus bare-metal stents. J. Am. Coll. Cardiol. 48: 2584-2591. doi:10.1016/j.jacc.2006.10.026
41. Pierstorff, E., M. Krucoff, D. Ho. 2008. Apoptosis induction and attenuation of inflammatory gene expression in murine macrophages via multitherapeutic nanomembranes. Nanotechnology. 19: 265103-265112. doi:10.1088/0957-4484/19/26/265103
40. Schäfer, O., F. Brink-Spalink, C. Schmidt, J.H. Wendorff, C. Witt, T. Kissel, A. Greiner. 1999. Synthesis and properties of omega-phenylalkyl-substituted poly(p-xylylene)s prepared by base-induced 1,6-dehydrohalogenation. Macromol. Chem. Phys. 200: 1942-1949. doi:10.1002/(SICI)1521-3935(19990801)200:8<1942::AID-MACP1942>3.0.CO;2-H
30. Shin, Y.S., K. Cho, S.H. Lim, S. Chung, S. Park, C. Chung, D. Han, J.K. Chang. 2003. PDMS-based micro PCR chip with Parylene coating. J. Micromech. Microeng. 13: 768-774. doi:10.1088/0960-1317/13/5/332
18. Sigler, M., T. Paul, R.G. Grabitz. 2005. Biocompatibility screening in cardiovascular implants. Z. Kardiol. 94: 383-391. doi:10.1007/s00392-005-0231-4
62. Smyth, G.P., P.P. Stapleton, T.A. Freeman, E.M. Concannon, J.R. Mestre, M. Duff, S. Maddali, J.M. Daly. 2004. Glucocorticoid pretreatment induces cytokine overexpression and nuclear factor-κB activation in macrophages. J. Surg. Res. 116: 253-261. doi:10.1016/S0022-4804(03)00300-7
57. Soderberg, M., F.Raffalli-Mathieu, M.A. Lang. 2007. Regulation of the murine inducible nitric oxide synthase gene by dexamethasone involves a heterogeneous nuclear ribonucleoprotein I (hnRNPI) dependent pathway. Mol. Immunology. 44: 3204-3210. doi:10.1016/j.molimm.2007.01.029
2. Sokolsky-Papkov, M., K. Agashi, A. Olaye, K. Shakesheff, A.J. Domb. 2007. Polymer carriers for drug delivery in tissue engineering. Adv. Drug Del. Rev. 59: 187-206. doi:10.1016/j.addr.2007.04.001
61. Sorrells, S.F., R.M. Sapolsky. 2007. An inflammatory review of glucocorticoids in the CNS. Brain, Behavior, and Immunity. 21: 259-272. doi:10.1016/j.bbi.2006.11.006
23. Stark, N. 1996. Literature review: biological safety of parylene c. Medical Plastics and Biomaterials. 3: 30-35.
19. Sutherland, K., J.R. Mahoney, A.J. Coury, and J.W. Eaton. 1993. Degradation of biomaterials by phagocyte-derived oxidants. J. Clin. Invest. 92: 2360-2367. doi:10.1172/JCI116841
36. Takeuchi, S., D. Ziegler, Y. Toshida, K. Mabuchi, T. Suzuki. 2005. Parylene flexible neural probes integrated with microfluidic channels. Lab on a Chip. 5: 519-523. doi:10.1039/b417497f
16. Tao, S. L., Desai, T. A. 2005. Gastrointestinal patch systems for oral drug delivery. Drug Discovery Today. 909-915. doi:10.1016/S1359-6446(05)03489-6
17. Tao, S. L., Desai, T. A. 2005. Microfabrication of multilayer, asymmetric, polymeric devices for drug delivery. Advanced Materials. 17: 1625-1630. doi:10.1002/adma.200500017
32. Tooker, A., E. Meng, J. Erickson, Y.-C. Tai, J. Pine. 2005. Biocompatible Parylene Neurocages. IEEE Eng. in Med. And Bio. 24: 30-33.
54. Truss, M., M. Beato. 1993. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr. Rev. 51: 459-479.
15. Tsutsui, Y., K. Tomizawa, M. Nagita, H. Michiue, T. Nishiki, I. Ohmori, M. Seno, H. Matsui. 2007. Development of bionanocapsules targeting brain tumors. J. Control. Rel. 122: 159-164. doi:10.1016/j.jconrel.2007.06.019
11. Westedt, U., M. Wittmar, M. Hellwig, P. Hanefeld, A. Greiner, A.K. Schaper, T. Kissel. 2006. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings. J. Control. Rel. 111: 235-245. doi:10.1016/j.jconrel.2005.12.012
24. Wolgemuth, L. 2000. Assessing the performance and suitability of parylene coating. Med. Dev. Diag. Ind. 22: 42-49.
7. Wong, H.L., R. Bendayan, A.M. Rauth, Y. Li, X.Y. Wu. 2007. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv. Drug Del. Rev. 59: 491-504. doi:10.1016/j.addr.2007.04.008
13. Yang, C., H.M. Burt. 2006. Drug-eluting stents: Factors governing local pharmacokinetics Adv. Drug Del. Rev. 58:402-411. doi:10.1016/j.addr.2006.01.017
44. Yang, G.-R., S. Ganguli, J. Karcz, W.N. Gill, T.-M. Lu. 1998. High deposition rate parylene films. J. Crystal Growth. 183: 385-390. doi:10.1016/S0022-0248(97)00428-4
27. Zeng, J., A. Aigner, F. Czubayko, T. Kissel, J. H. Wendorff, A. Greiner. 2005. Poly(vinyl alcohol) nanofibers by electrospinning as a protein delivery system and the retardation of enzyme release by additional polymer coatings. Biomacromol. 6: 1484-1488. doi:10.1021/bm0492576
8. Zhang, G., L.J. Suggs. 2007. Matrices and scaffolds for drug delivery in vascular tissue engineering. Adv. Drug Del. Rev. 59: 360-373. doi:10.1016/j.addr.2007.03.018
14. Zhong, Y., R.V. Bellamkonda. 2007. Dexamethasone coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probes. Brain Res. 1148: 15-27. doi:10.1016/j.brainres.2007.02.024
34. Ziegler, D., T. Suzuki, S. Takeuchi. 2006. Fabrication of flexible neural probes with built-in microfluidic channels by thermal bonding of parylene. J. Microelectromech. Sys. 15: 1477-1482. doi:10.1109/JMEMS.2006.879681
Acknowledgments
D. H. gratefully acknowledges support from a National Science Foundation CAREER Award, V Foundation for Cancer Research V Scholars Award, National Science Foundation Center for Scalable and Integrated NanoManufacturing (SINAM) Grant DMI-0327077, Wallace H. Coulter Foundation Early Career Award in Translational Research, and National Institutes of Health grant U54 A1065359. M. Chen acknowledges support from the Weinberg College of Arts and Sciences of Northwestern University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, M., Huang, H., Pierstorff, E. et al. Parylene-Encapsulated Copolymeric Membranes as Localized and Sustained Drug Delivery Platforms. Ann Biomed Eng 37, 2003–2017 (2009). https://doi.org/10.1007/s10439-009-9662-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-009-9662-9